Hvivo PLC (HVO)

16.30
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    16.30 - 16.34

HVO Overview

Prev. Close
16.75
Day's Range
16.3-16.34
Revenue
14.92M
Open
16.75
52 wk Range
8.68-20.5
EPS
-0.002
Volume
0
Market Cap
109.36M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,157,171
P/E Ratio
-64.35
Beta
0.811
1-Year Change
-16.41%
Shares Outstanding
670,929,314
Next Earnings Date
04 Jun 2023
What is your sentiment on Hvivo?
or
Vote to see community's results!

Hvivo PLC News

Hvivo PLC Company Profile

Hvivo PLC Company Profile

hVIVO plc, formerly Open Orphan plc, is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. It provides end-to-end early clinical development services to its client base, which includes global biopharma companies. It offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. It offers additional clinical field trial services, such as patient recruitment and clinical trial site services. It runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

Read More

Analyst Price Target

Average0.38 (-97.68% Downside)
High0.5433
Low0.2836
Price16.30
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralBuyStrong Buy
Technical IndicatorsBuySellStrong SellStrong BuyNeutral
SummaryNeutralSellSellStrong BuyBuy
  • Great news! Huge potential. Buying opportunity IMO DYOR
    1
    • Excellent presentation by Executive Chairman 11/6/20: https://www.openorphan.com/sites/openorphan-v2/files/2020-06/Open_Orphan_Investor_Presentation-June_2020_3.pdf HUGE  potential. DYOR!
      0
      • Open Orphan launches “best-in-class" coronavirus testing service 2020-06-04 07:53:00
        0
        • whats goin on
          0
      • Nigel i do like ORPH but i think they are a little to far behind the likes of Genedrive,and today they have the  CE Mark to start selling to the world.Plus ORPH have just had a Placing which will hold them back as it did with Gnedrive 2 weeks ago. good luck
        1
        • Cheers Paul i think it is interesting times for both companies .I still dont think folk understand what ORPH are about
          0
      • i looked at them but genedrive got my vote after many hours of research
        0
        • Interesting Paul ,good luck
          0
        • Paul i think ORPH is a sleeping giant.
          0
        • Good morning Paul any views on share price .Genedrive on my radar .
          0
      • Anybody following ORPH
        1